DAVID BATES to Clinical Trials as Topic
This is a "connection" page, showing publications DAVID BATES has written about Clinical Trials as Topic.
Connection Strength
0.070
-
Clinical impact of drug-drug interactions with systemic azole antifungals. Drugs Today (Barc). 2003 Oct; 39(10):801-13.
Score: 0.037
-
Projected impact of monoclonal anti-endotoxin antibody therapy. Arch Intern Med. 1994 Jun 13; 154(11):1241-9.
Score: 0.019
-
Protecting an endangered species: training physicians to conduct clinical research. Acad Med. 2009 Apr; 84(4):439-45.
Score: 0.014